Catalyst Wire Dossier Catalyst Wire Dossier

Doxylamine succinate and pyridoxine hydrochloride, delayed-release tablets 10 mg/10 mg

Doxylamine succinate and pyridoxine hydrochloride · Endo USA, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Doxylamine succinate and pyridoxine hydrochloride, delayed-release tablets 10 mg/10 mg, covering 2017-12-06 to 2017-12-06. Get the full timeline:

Most recent: FDA Approved: DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE — Original Application (Endo USA, Inc.)

See pricing